ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag books behavior hiv disease medicine

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
Battling Bad Behavior
McDonnell Social Norms Group | Feb 1, 2006 | 10+ min read
FEATUREBattling Bad Behavior COURTESY YURI MATROSOVICHAnti-alcohol propaganda such as this poster titled "Bartered" was distributed in the Soviet Union during the 1980s Many of society's most vexing problems - the rise of antibiotic resistance, the current epidemic of obesity, armed conflicts that leave both sides worse off - have their roots in the suboptimal and often puzzling actions of individuals. At times
Collage of those featured in the article
Remembering Those We Lost in 2021
Lisa Winter | Dec 23, 2021 | 5 min read
As the year draws to a close, we look back on researchers we bid farewell to, and the contributions they made to their respective fields.
The AIDS Research Evaluators
Lynn Gambale | Jul 9, 1995 | 6 min read
Chairman: Arnold Levine, chairman, department of molecular biology, Princeton University Barry Bloom, Weinstock Professor and Howard Hughes Medical Institute (HHMI) investigator, department of microbiology and immunology, Albert Einstein College of Medicine, New York Rebecca Buckley, professor of pediatrics and immunology, Duke University Medical Center Charles Carpenter, chairman, Office of AIDS Research Advisory Committee; professor of medicine,Brown University School of Medicine Don
obituary, obituaries, roundup, end of the year, COVID-19, SARS-CoV-2, pandemic, coronavirus, immunology, genetics & genomics, cell & molecular biology, HIV
Those We Lost in 2020
Amanda Heidt | Dec 18, 2020 | 7 min read
The scientific community bid farewell to researchers who furthered the fields of molecular biology, virology, sleep science, and immunology, among others.
Show Me The Data: A Nobel Lesson In The Process Of Science
Barry Palevitz | Dec 7, 1997 | 5 min read
The recent award of the Nobel Prize in physiology or medicine to Stanley Prusiner, a professor of neurology, virology, and biochemistry at the University of California, San Francisco, for his work on prions sharpened the focus on the concept of data-driven ideas in science. In contrast is the challenge to the well-accepted idea that HIV causes AIDS by Peter Duesberg, a professor of molecular and cellular biology at the University of California, Berkeley. The two hypotheses are iconoclastic, ear
AIDS Investigators Cautiously Applauding Recent Advances
Steven Benowitz | Sep 29, 1996 | 10+ min read
Discoveries announced at conference leave scientists feeling optimistic; yet their enthusiasm is tempered by several persistent concerns. AIDS researchers have many reasons to be encouraged. Studies show that treatments combining new and old drugs can control HIV levels in the blood. Moreover, many scientists and activists note, prevention efforts have helped reduce HIV infection rates. Yet the enthusiasm is tempered by several caveats. Drugs are expensive and have harsh side effects, leading
The Scientist Staff | Mar 28, 2024
Mind-Body Research Calls For Evidence
Steve Bunk | Jan 9, 2000 | 4 min read
One measure of the rising interest in mind-body medicine is the increasing entry of young physicians into specialties that focus on the interface between mental and physical disorders. Yet there is a dire need for controlled, clinical trials of treatments that address this interface in a variety of complex disorders. Such evidence-based support is especially important to doctors who specialize in psychosomatic medicine, because they face a cost-cutting threat from managed care groups. These were
Ethical Debate on Placebo Use May Prompt New Trial Designs
Steve Bunk | Sep 13, 1998 | 8 min read
For a thing that is "nothing," placebo has been much in the news lately. Whenever the media have mentioned placebo this year, it often has been in the context of clinical trials overseas for treatments to prevent perinatal HIV transmission. The studies were controversial because most of them employed placebo controls with the various treatments being tested, although trials in the United States and France already had indicated that the antiretroviral drug zidovudine (AZT) reduced the incidence

Run a Search

ADVERTISEMENT